LIVER CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s News Tips And Features Other News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.

November 13, 2018

Keytruda Immunotherapy for Treatment of Liver Cancer

By Anonymous User anonymous_user_10987

According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib), (1) and has not been approved by the US for use in patients with liver cancer. Keytruda was approved as a […]

View full entry

Tags: Liver Cancer, News Tips and Features, News Tips and Features Other


October 19, 2018

Laurie MacCaskill Partners with CancerConnect

By Anonymous User anonymous_user_10987

KETCHUM – LOS ANGELES: Laurie MacCaskill, a 12-year survivor of pancreatic cancer and former chair of the Pancreatic Cancer Action Network has announced a newly established partnership with Cancer Connect to support pancreatic cancer patients with information, support and inspiration. Cancer Connect, a national organization provides support and information to more than 1 million patients […]

View full entry

Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer


August 20, 2018

FDA Approves Lenvatinib for Treatment of Advanced Hepatocellular Cancer

By Anonymous User anonymous_user_10987

The U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). This approval was based on results from REFLECT, where LENVIMA demonstrated a proven treatment effect on overall survival as well as statistically significant superiority and clinically meaningful improvements in progression-free survival […]

View full entry

Tags: Liver Cancer, News Tips and Features, News Tips and Features Other


July 12, 2018

Cyramza Improves Survival in Poor-Prognosis Liver Cancer

By Anonymous User anonymous_user_10987

Andrew X. Zhu, MD, PhD, director of Liver Cancer Research at Massachusetts General Hospital presented new data at the 2018 World Congress on Gastrointestinal Cancer (WCGC) demonstrating that Cyramza (ramucirumab) significantly improves survival in a subset of patients with hepatocellular carcinoma (HCC) who have high levels of the plasma protein α-fetoprotein (AFP), which is associated […]

View full entry

Tags: cyramza, hepatocellular cancer treatment, Liver Cancer, News Tips and Features, News Tips and Features Other


June 19, 2018

mFOLFIRINOX Found Superior to Gemzar for Treatment Surgically Resected Pancreatic Cancer

By Anonymous User anonymous_user_10987

The results of a recently presented clinical study at the American Society of Clinical Oncology meetings last week suggest that more aggressive chemotherapy treatment improves outcomes compared to single agent Gemzar (gemcitabine) chemotherapy which has been a standard treatment for over a decade. About Pancreatic Cancer Pancreatic cancer is one of the deadliest forms of […]

View full entry

Tags: Chemotherapy, gemzar, mFOLFIRINOX, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, treatment


FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

May 24, 2018

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

By cancerconnect cancerconnect

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of withdrawal symptoms, it may […]

View full entry

Tags: News Tips and Features, News Tips and Features Other


Irritable Bowel Syndrome Tips for Symptom Management

May 16, 2018

Irritable Bowel Syndrome Tips for Symptom Management

By cancerconnect cancerconnect

Bloating is a common symptom in individuals with irritable bowel syndrome (IBS), particularly in women. Bloating may be the only symptom for some people with IBS and although not typically serious is quite discomforting. Irritable bowel syndrome is a disorder that affects the large intestine, or colon. Its symptoms include cramping, abdominal pain, bloating, constipation, […]

View full entry

Tags: Bloating, Irritable Bowel Syndrome, News Tips and Features, News Tips and Features Other, Tips for Symptom Management


Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

April 25, 2018

Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

By Anonymous User anonymous_user_10987

CancerConnect News: One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her cancer risk and many of these mutations could go undetected with the current screening approach, according to initial data from a statewide colorectal cancer screening study conducted at […]

View full entry

Tags: Colon Cancer, hereditary, lynch syndrome, News Tips and Features, News Tips and Features Other, ohio state-james cancer institute


View more articles like this
More news and in-depth Colon Cancer information

CONDITIONS OF THE GI TRACT